News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and…
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small…
An analysis from the Phase 3 CheckMate 77T trial confirms that perioperative nivolumab does not…
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously…
A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a…
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Blood cancer patients in the US who may have previously struggled to find a donor…
Australian researchers have demonstrated that the use of a new, less toxic drug combination after…
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.